Results 231 to 240 of about 66,698 (357)

Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Tumor lysis syndrome (TLS) arises from the rapid breakdown of tumor cells during oncological treatment. Although TLS is rarely observed in solid tumors, few studies have documented instances of TLS associated with pembrolizumab. This report presents a case involving pembrolizumab‐induced TLS.
Takashi Asakura, Toshiaki Shinojima, Shinnosuke Hiruta, Hirotaka Asakura   +3 more
wiley   +1 more source

<i>Thyrotropin-Releasing Hormone</i> Gene Methylation as a Potential Biomarker for Anal Intraepithelial Neoplasia. [PDF]

Int J Mol Sci
Pholpong C, Phanuphak N, Pankam T, Buranapraditkun S, Kitkumthorn N, Lee B, Bhattarakosol P, Chaiwongkot A.   +7 more
europepmc   +1 more source

Hypothalamic and pituitary control of thyroid function [PDF]

, 1974
Dunn, John T., Madeiros-Neto, Geraldo A., Scriba, Peter Christian   +2 more
core   +1 more source

Long‐Term Outcomes of Radiofrequency Ablation for Benign Thyroid Nodules of Different Sizes: Implications of Regrowth and New Growth

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 1, January 2026.
ABSTRACT Radiofrequency ablation is an effective treatment for benign thyroid nodules. Since initial nodule volume may impact the efficacy of radiofrequency ablation, this study evaluated its long‐term outcomes across varying nodule sizes, focusing on regrowth, new growth, and clinical management implications.
Chia‐Yin Lu, An‐Ni Lin, Cheng‐Kang Wang, Pi‐Ling Chiang, Chen‐Kai Chou, Sheng‐Dean Luo, Yueh‐Sheng Chen, Chih‐Ying Lee, Jung‐Hwan Baek, Hsiu‐Ling Chen, Wei‐Che Lin   +10 more
wiley   +1 more source

Results of oral TRH test in the differentiation of compensated and decompensated autonomous thyroid nodules [PDF]

, 1982
A Ribka, D Jüngst, D. Jüngst, EC Ridgway, H. J. Karl, JJ Staub, P Vogt, U. Büll   +7 more
core   +1 more source

Case Report: Compound Heterozygous SCNN1B Mutations Causing Pseudohypoaldosteronism Type 1B2 in Neonatal Twins

Molecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
First Chinese neonatal cases of systemic PHA1B from novel compound‐heterozygous SCNN1B variants (c.585+2T>C; c.1544T>C) presented with life‐threatening hyperkalemia and hyponatremia unresponsive to steroids. Early genetic testing enabled targeted sodium supplementation and potassium‐binding therapy, normalizing electrolytes and underscoring SCNN1B ...
Zhiping Wang, Lijuan Long, Hongjuan Bi
wiley   +1 more source

High TRAb Titer at Diagnosis Predicts Persistent Positivity and Relapse in Graves' Disease after Prolonged Antithyroid Therapy. [PDF]

Endocrinol Metab (Seoul)
Chen Z, Xu J, Kang W, Zhang Y, Chen R, Gong X.   +5 more
europepmc   +1 more source

Automatization of serum thyroxine determination and of T3-uptake test [PDF]

, 1972
Habermann, J., Henner, J., Horn, K., Horst, I. zur, Scriba, Peter Christian   +4 more
core   +1 more source

Topiramate Enhances GABAergic Tone to Orexigenic Neuropeptide Y/Agouti‐Related Peptide (NPY/AgRP) Neurons

Obesity, Volume 34, Issue 1, Page 175-187, January 2026.
ABSTRACT Objective Topiramate is a medication used off‐label, or in combination with phentermine, for the management of obesity. However, its mechanism of action remains elusive. As many obesity medications target the brain, we aimed to determine if topiramate influences the activity of hypothalamic melanocortin neurons known to regulate energy balance.
Moein Minbashi Moeini, Olivier Lavoie, Alexandre Caron, Kevin W. Williams, Natalie J. Michael   +4 more
wiley   +1 more source

Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case report. [PDF]

Thyroid Res
Armenti M, Maioli S, Riva C, Currò N, Moschetti G, Salvi M, Muller I.   +6 more
europepmc   +1 more source